Uptake of codeine into intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 1, 2010, Pages 31-42

  Fischer, Wiebke ^a   Bernhagen, Jennifer ^a   Neubert, Reinhard H H ^a   Brandsch, Matthias ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Caco 2 cells; Codeine; Drug delivery; Membrane transport; Opioids; RBE4 cells

Indexed keywords

AMINO ACID; CATION; CODEINE; NEUROTRANSMITTER; OPIATE; TRITIUM;

ARTICLE; BRAIN CELL; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG UPTAKE; EPITHELIUM CELL; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; BRAIN; CACO 2 CELL LINE; CELL CULTURE; CYTOLOGY; ENDOTHELIUM; HUMAN; INTESTINE MUCOSA; METABOLISM; VASCULARIZATION;

BRAIN; CACO-2 CELLS; CELLS, CULTURED; CODEINE; ENDOTHELIUM; HUMANS; INTESTINAL MUCOSA; TRITIUM;

EID: 77954760331     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.05.010     Document Type: Article

References (37)

1. + antiporter that interacts with addictive drugs. J. Cereb. Blood Flow Metab. 2009, 29:1293-1304.
2. +-dependent sugar transport in Caco-2 cells and human fetal colon. J. Membr. Biol. 1987, 99:113-125.
3. Bolser D.C., Davenport P.W. Codeine and cough: an ineffective gold standard. Curr. Opin. Allergy Clin. Immunol. 2007, 7:32-36.
4. +/peptide symporter (PEPT1), the uptake into Caco-2 cell monolayers and the transepithelial flux. Pharm. Res. 1999, 16:55-61.
5. Chen Z.R., Somogyi A.A., Reynolds G., Bochner F. Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers. Br. J. Clin. Pharmacol. 1991, 31:381-390.
6. Dale O., Nilsen T., Olaussen G., Tvedt K.E., Skorpen F., Smidsrød O., Vårum K.M. Transepithelial transport of morphine and mannitol in Caco-2 cells: the influence of chitosans of different molecular weights and degrees of acetylation. J. Pharm. Pharmacol. 2006, 58:909-915.
7. Fischer W., Metzner L., Hoffmann K., Neubert R.H., Brandsch M. Substrate specificity and mechanism of the intestinal clonidine uptake by Caco-2 cells. Pharm. Res. 2006, 23:131-137.
8. Fischer W., Praetor K., Metzner L., Neubert R.H.H., Brandsch M. Transport of valproate at intestinal epithelial (Caco-2) and brain endothelial (RBE4) cells: mechanism and substrate specificity. Eur. J. Pharm. Biopharm. 2008, 70:486-492.
9. Hau V.S., Huber J.D., Campos C.R., Davis R.T., Davis T.P. Effect of λ-carrageenan-induced inflammatory pain on brain uptake of codeine and antinociception. Brain Res. 2004, 1018:257-264.
10. Heikkinen A.T., Mönkkönen J., Korjamo T. Kinetics of cellular retention during Caco-2 permeation experiments: role of lysosomal sequestration and impact on permeability estimates. J. Pharmacol. Exp. Ther. 2009, 328:882-892.
11. Henthorn T.K., Liu Y., Mahapatro M., Ng K.Y. Active transport of fentanyl by the blood-brain barrier. J. Pharmacol. Exp. Ther. 1999, 289:1084-1089.
12. Huwyler J., Fricker G., Torok M., Schneider M., Drewe J. Transport of clonidine across cultured brain microvessel endothelial cells. J. Pharmacol. Exp. Ther. 1997, 282:81-85.
13. Kim I., Barnes A.J., Oyler J.M., Schepers R., Joseph R.E., Cone E.J., Lafko D., Moolchan E.T., Huestis M.A. Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin. Chem. 2002, 48:1486-1496.
14. Knütter I., Hartrodt B., Theis S., Foltz M., Rastetter M., Daniel H., Neubert K., Brandsch M. Analysis of the transport properties of side chain modified dipeptides at the mammalian peptide transporter PEPT1. Eur. J. Pharm. Sci. 2004, 21:61-67.
15. Koepsell H., Lips K., Volk C. Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm. Res. 2007, 24:1227-1251.
16. Kuwayama K., Inoue H., Kanamori T., Tsujikawa K., Miyaguchi H., Iwata Y., Miyauchi S., Kamo N., Kishi T. Uptake of 3,4-methylenedioxymethamphetamine and its related compounds by a proton-coupled transport system in Caco-2 cells. Biochim. Biophys. Acta 2008, 1778:42-50.
17. Liu J., Subir M., Nguyen K., Eisenthal K.B. Second harmonic studies of ions crossing liposome membranes in real time. J. Phys. Chem. B 2008, 112:15263-15266.
18. Marks M.J., Medzihradsky F. Transport and interaction of drugs in leukocytes. Biochem. Pharmacol. 1974, 23:2951-2962.
19. + in human intestinal epithelial (Caco-2) cells. Naunyn. Schmiedebergs Arch. Pharmacol. 2000, 361:505-513.
20. Martel F., Monteiro R., Lemos C. Uptake of serotonin at the apical and basolateral membranes of human intestinal epithelial (Caco-2) cells occurs through the neuronal serotonin transporter (SERT). J. Pharmacol. Exp. Ther. 2003, 306:355-362.
21. Mason M., Wolf M.E., Mosnaim A.D. Studies in the mechanism of phenylethylamine uptake by rabbit erythrocytes. Comp. Biochem. Physiol. 1983, 76:215-219.
22. +/peptide cotransporters PEPT1 and PEPT2 in intestinal and renal epithelial cells. Eur. J. Biochem. 2004, 271:2012-2017.
23. Mizuuchi H., Katsura T., Saito H., Hashimoto Y., Inui K.I. Transport characteristics of diphenhydramine in human intestinal epithelial Caco-2 cells: contribution of pH-dependent transport system. J. Pharmacol. Exp. Ther. 1999, 290:388-392.
24. Mizuuchi H., Katsura T., Assida K., Hashimoto Y., Inui K.I. Diphenhydramine transport by pH-dependent tertiary amine transport system in Caco-2 cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278:G563-G569.
25. Nakazawa Y., Okura T., Shimomura K., Terasaki T., Deguchi Y. Drug-drug interaction between oxycodone and adjuvant analgesics in blood-brain barrier transport and antinociceptive effect. J. Pharm. Sci. 2009, 9:467-474.
26. Okura T., Hattori A., Takano Y., Sato T., Hammarlund-Udenaes M., Terasaki T., Deguchi Y. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone. Drug Metab. Dispos. 2008, 36:2005-2013.
27. Oldendorf W.H., Hyman S., Braun L., Oldendorf S.Z. Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection. Science 1972, 178:984-986.
28. a, lipophilicity, solubility, absorption, and polar surface area of some centrally acting antihypertensives. Bioorg. Med. Chem. 2006, 14:1715-1728.
29. Rogers J.F., Findlay J.W., Hull J.H., Butz R.F., Jones E.C., Bustrack J.A., Welch R.M. Codeine disposition in smokers and nonsmokers. Clin. Pharmacol. Ther. 1982, 32:218-227.
30. Scrafani J.T., Hug C.C. Active uptake of dihydromorphine and other narcotic analgesics by cerebral cortical slices. Biochem. Pharmacol. 1968, 17:1557-1566.
31. Somogyi A.A., Barratt D.T., Coller J.K. Pharmacogenetics of opioids. Clin. Pharmacol. Ther. 2007, 81:429-444.
32. Spahn H., Altmeyer P., Cattarius-Korb S., Krüger B., Lang E., Mutschler E., Sörgel F. The bioavailability of combination preparations of acetylsalicylic acid and codeine phosphate. Arzneimittelforschung 1985, 35:973-976.
33. Thorn C.F., Klein T.E., Altman R.B. Codeine and morphine pathway. Pharmacogenet. Genomics 2009, 19:556-558.
34. Wang Y., Cao J., Wang X., Zeng S. Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers. Chirality 2009, 22:361-368.
35. 1-antagonist at the blood-brain barrier: transport mechanism of mepyramine using the carotid injection technique. Biol. Pharm. Bull. 1994, 17:676-679.
36. 1-antagonist at the blood-brain barrier: mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures. Pharm. Res. 1994, 11:975-978.
37. Xie R., Hammarlund-Udenaes M. Blood-brain barrier equilibration of codeine in rats studied with microdialysis. Pharm. Res. 1998, 15:570-575.